Women’s Health Rehabilitation Products Market to Expand at a CAGR of 5.0% During 2016 – 2024

According to the report, the global women’s health rehabilitation products market will expand at a CAGR of 5.0% over the period between 2016 and 2024, rising from a valuation of US$2.6 bn in 2015 to US$4.2 bn by 2024.With no clear leader and the presence of a large number of regional companies, the global market for women’s health rehabilitation products features a largely fragmented and intensely competitive vendor landscape, observes Transparency Market Research in a recent report. To stand their grounds in the intensely competitive scenario, companies are putting more focus on research and development activities with the view of developing innovative and cost-effective product varieties. Companies are also putting more emphasis on acquisitions and mergers in a bid to consolidate their positions and the market in general.

North America and Europe to Remain Leading Regional Markets

From a geographical standpoint, the markets for women’s health rehabilitation products in North America and Europe collectively held the dominant share in the overall market in 2015. The North America market, home to several medical devices and product companies, valued at nearly US$1 bn in 2015. Exhibiting a healthy CAGR of 4.9% over the period between 2016 and 2024, the regional market is likely to remain one of the most promising marketplaces for women’s health rehabilitation products in the near future as well.

Request A Sample-

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=13022

Factors such as the rising geriatric population and rise in number of accidents will ramp up the overall demand for women’s health rehabilitation products in North America. Over the forecast period, however, the market in Asia Pacific is expected to emerge as the most promising, thanks to rising awareness, rising disposable incomes, and an improving state of the region’s healthcare scenario.

On the basis of product, the segment of urinary incontinence treatment post prolonged illnesses is likely to exhibit the maximum CAGR over the forecast period.

Leave a Reply